|
Name |
2-Methyl-4-heptanone
|
Molecular Formula | C8H16O | |
IUPAC Name* |
2-methylheptan-4-one
|
|
SMILES |
CCCC(=O)CC(C)C
|
|
InChI |
InChI=1S/C8H16O/c1-4-5-8(9)6-7(2)3/h7H,4-6H2,1-3H3
|
|
InChIKey |
AKRJXOYALOGLHQ-UHFFFAOYSA-N
|
|
Synonyms |
2-Methyl-4-heptanone; 2-Methylheptan-4-one; 626-33-5; 4-Heptanone, 2-methyl-; Isobutyl propyl ketone; 9EPS3PVK5G; ISOBUTYL n-PROPYL KETONE; EINECS 210-943-1; AI3-28138; UNII-9EPS3PVK5G; SCHEMBL104701; DTXSID4060816; AKRJXOYALOGLHQ-UHFFFAOYSA-; ZINC1845920; LMFA12000100; MFCD00027143; AKOS009159339; LS-13505; DB-054224; CS-0454369; FT-0632637; M0694; T72726
|
|
CAS | 626-33-5 | |
PubChem CID | 69378 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 128.21 | ALogp: | 2.0 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 9 | QED Weighted: | 0.568 |
Caco-2 Permeability: | -4.286 | MDCK Permeability: | 0.00003040 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.349 |
30% Bioavailability (F30%): | 0.177 |
Blood-Brain-Barrier Penetration (BBB): | 0.998 | Plasma Protein Binding (PPB): | 46.84% |
Volume Distribution (VD): | 0.927 | Fu: | 55.99% |
CYP1A2-inhibitor: | 0.536 | CYP1A2-substrate: | 0.732 |
CYP2C19-inhibitor: | 0.156 | CYP2C19-substrate: | 0.844 |
CYP2C9-inhibitor: | 0.225 | CYP2C9-substrate: | 0.948 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.392 |
CYP3A4-inhibitor: | 0.014 | CYP3A4-substrate: | 0.207 |
Clearance (CL): | 10.247 | Half-life (T1/2): | 0.877 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.102 |
Drug-inuced Liver Injury (DILI): | 0.264 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.039 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.148 | Carcinogencity: | 0.037 |
Eye Corrosion: | 0.891 | Eye Irritation: | 0.982 |
Respiratory Toxicity: | 0.078 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000231 | 0.486 | D00WUF | 0.342 | ||||
ENC000241 | 0.484 | D0ZK8H | 0.303 | ||||
ENC000237 | 0.481 | D0Y3KG | 0.289 | ||||
ENC000376 | 0.429 | D05PLH | 0.250 | ||||
ENC000351 | 0.429 | D0G8SQ | 0.250 | ||||
ENC000645 | 0.415 | D02KBD | 0.231 | ||||
ENC000228 | 0.410 | D0R6BR | 0.226 | ||||
ENC000718 | 0.410 | D0OL6O | 0.225 | ||||
ENC001015 | 0.405 | D0HD9K | 0.222 | ||||
ENC000188 | 0.400 | D07ZTO | 0.220 |